Consider This: Dengue Vaccine (Part 3) — Pandemic Lessons: Prevent Vaccine Inequity

The Government recently granted conditional approval for Qdenga, the first dengue vaccine to be approved for use in Malaysia. This comes in the wake of an alarming 86% surge in dengue cases last year— with 100 fatalities reported— underscoring an urgent public health challenge. With a national goal of zero dengue-related deaths by 2030, how will the introduction of Qdenga shape Malaysia’s battle against this relentless disease? On this episode of #ConsiderThis Melisa Idris speaks to Vanessa Daniel, Acting Director of the Southeast Asia Regional Office for the Drugs for Neglected Diseases Initiative (DNDi) which is a non-profit which seeks to ensure treatment for neglected diseases are available, affordable, and adapted to the communities who need them.